Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS)

被引：0
|
作者：
Badawy, Mohmed [1 ]
Johnson, Geoffrey B. [1 ]
Hobday, Timothy [1 ]
Packard, Annie T. [1 ]
Jain, Manoj [2 ]
Halfdanarson, Thorvardur R. [1 ]
Young, Jason R. [1 ]
Thorpe, Matthew P. [1 ]
Eiring, Rachel A. [1 ]
Kendi, Ayse Tuba [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
来源：
PANCREAS | 2022年 / 51卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
C-24
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [41] The role of 177Lu-Dotatate peptide receptor radionuclide treatment in patients with metastatic well differentiated gastrointestinal neuroendocrine tumors (GI-NETs)
    Severi, S.
    Sansovini, M.
    Ambrosetti, A.
    Ianniello, A.
    Scarpi, E.
    Nanni, O.
    Sarnelli, A.
    Di Iorio, V.
    Garaboldi, L.
    Matteucci, F.
    Bartolomei, M.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S233 - S233
  • [42] Increased Tumor Size and Progression Free Survival after 177Lu-DOTATATE for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Patel, J.
    Zhang, K.
    Gbolahan, O. B.
    Schuster, D. M.
    Muzahir, S.
    Patel, P. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E477 - E478
  • [43] A clinical score (CS) for patients with well-differentiated neuroendocrine tumors (WD NETs) under consideration for peptide receptor radionuclide therapy (PRRT) with Lu 177-dotatate.
    Das, Satya
    Du Liping
    Schad, Aimee
    Jain, Shikha
    Jessop, Aaron
    Shah, Chirayu
    Eisner, David
    Cardin, Dana Backlund
    Ciombor, Kristen Keon
    Goff, Laura Williams
    Bradshaw, Marques
    Delbeke, Dominique
    Sandler, Martin P.
    Berlin, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [44] Polish Multicenter Experience with Tandem Peptide Receptor Radionuclide Therapy Using 90Y/177Lu-DOTATATE in Neuroendocrine Tumors
    Kunikowska, J.
    Zemczak, A.
    Kolodziej, M.
    Gut, P.
    Lon, I
    Pawlak, D.
    Mikolajczak, R.
    Kaminski, G.
    Ruchala, M.
    Kos-Kudla, B.
    Krolicki, L.
    NEUROENDOCRINOLOGY, 2019, 108 : 216 - 216
  • [45] Peptide Receptor Radionuclide Therapy by 177Lu-DOTATATE of a Secreting Cervical Paraganglioma
    Deville, Agathe
    Pinigina, Iuliia
    Al Mansour, Laure
    Abeillon, Juliette
    Tordo, Jeremie
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E71 - E73
  • [46] Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action
    Assadi, Majid
    Rekabpour, Seyed Javad
    Amini, Abdullatif
    Dadgar, Habibollah
    Nemati, Reza
    Gholamrezanezhad, Ali
    Nabipour, Iraj
    Jafari, Esmail
    Ahmadzadehfar, Hojjat
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 107 - 109
  • [47] In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy
    Lubberink, Mark
    Wilking, Helena
    Ost, Amalia
    Ilan, Ezgi
    Sandstrom, Mattias
    Andersson, Camilla
    Fross-Baron, Katarzyna
    Velikyan, Irina
    Sundin, Anders
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (09) : 1337 - 1340
  • [48] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Nautiyal, Amit
    Michopoulou, Sofia
    Guy, Matt
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (02) : 157 - 175
  • [49] Safety of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease
    Alsadik, Shahad
    Gnanasegaran, Gopinath
    Chen, Luohai
    Mandair, Dalvinder
    Toumpanakis, Christos
    Caplin, Martyn
    Navalkissoor, Shaunak
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1503 - 1508
  • [50] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Amit Nautiyal
    Sofia Michopoulou
    Matt Guy
    Clinical and Translational Imaging, 2024, 12 : 157 - 175
12345